• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

端粒长度、遗传变异性与乳腺癌临床病理特征的相关性分析。

Relationship between Telomere Length, Genetic Variability and , , , Gene Co-Expression in the Clinicopathological Profile of Breast Cancer.

机构信息

Laboratory of Clinical Immunogenetics and Pharmacogenetics, Hirszfeld Institute of Immunology and Experimental Therapy, Polish Academy of Sciences, 53-114 Wroclaw, Poland.

Department of Pharmaceutical Technology and Biochemistry Faculty of Chemistry, Gdansk University of Technology, 80-233 Gdansk, Poland.

出版信息

Int J Mol Sci. 2022 May 5;23(9):5164. doi: 10.3390/ijms23095164.

DOI:10.3390/ijms23095164
PMID:35563554
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9102200/
Abstract

The molecular mechanisms of telomerase reverse transcriptase ( upregulation in breast cancer (BC) are complex. We compared genetic variability within and telomere length with the clinical data of patients with BC. Additionally, we assessed the expression of the , , and genes in BC patients and in BC organoids (3D cell cultures obtained from breast cancer tissues). We observed the same correlation in the blood of BC patients and in BC organoids between the expression of and . Only in BC patients was a correlation found between the expression of the and genes and between and . We found associations between genotypes (rs2735940 and rs10069690) and expression and telomere length. BC patients with the genotype rs2735940 have a shorter telomere length, but patients with allele rs10069690 have a longer telomere length. BC patients with a short allele VNTR-MNS16A showed higher expression of the and had a longer telomere. Our results bring new insight into the regulation of , , and gene expression related to genetic variability and telomere length. Our study also showed for the first time a similar relationship in the expression of the above genes in BC patients and in BC organoids. These findings suggest that genetic variability, expression and telomere length might be useful biomarkers for BC, but their prognostic value may vary depending on the clinical parameters of BC patients and tumor aggressiveness.

摘要

端粒酶逆转录酶 (TERT) 的分子机制在乳腺癌 (BC) 中上调是复杂的。我们比较了 和端粒长度的基因多态性与 BC 患者的临床数据。此外,我们还评估了 BC 患者和 BC 类器官(从乳腺癌组织中获得的 3D 细胞培养物)中 、 、 和 基因的表达。我们在 BC 患者的血液和 BC 类器官中观察到 和 之间相同的相关性。只有在 BC 患者中, 和 基因之间以及 和 之间的表达才存在相关性。我们发现 基因型(rs2735940 和 rs10069690)与 表达和端粒长度之间存在关联。携带 rs2735940 基因型的 BC 患者端粒较短,但携带 rs10069690 等位基因的患者端粒较长。具有短等位基因 VNTR-MNS16A 的 BC 患者 和 基因表达较高,端粒较长。我们的研究结果为与 基因遗传多态性和端粒长度相关的 、 、 和 基因表达调控提供了新的见解。我们的研究还首次表明,BC 患者和 BC 类器官中上述基因的表达存在相似的关系。这些发现表明, 基因遗传多态性、表达和端粒长度可能是 BC 的有用生物标志物,但它们的预后价值可能因 BC 患者的临床参数和肿瘤侵袭性而异。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f1e0/9102200/9db484dee1d4/ijms-23-05164-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f1e0/9102200/980b4fdf980e/ijms-23-05164-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f1e0/9102200/ab18838375cc/ijms-23-05164-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f1e0/9102200/acfe6907f88f/ijms-23-05164-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f1e0/9102200/d8be49d4108f/ijms-23-05164-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f1e0/9102200/d8be49d4108f/ijms-23-05164-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f1e0/9102200/9db484dee1d4/ijms-23-05164-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f1e0/9102200/980b4fdf980e/ijms-23-05164-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f1e0/9102200/ab18838375cc/ijms-23-05164-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f1e0/9102200/acfe6907f88f/ijms-23-05164-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f1e0/9102200/d8be49d4108f/ijms-23-05164-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f1e0/9102200/d8be49d4108f/ijms-23-05164-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f1e0/9102200/9db484dee1d4/ijms-23-05164-g006.jpg

相似文献

1
Relationship between Telomere Length, Genetic Variability and , , , Gene Co-Expression in the Clinicopathological Profile of Breast Cancer.端粒长度、遗传变异性与乳腺癌临床病理特征的相关性分析。
Int J Mol Sci. 2022 May 5;23(9):5164. doi: 10.3390/ijms23095164.
2
Telomere length, telomere-related genes, and breast cancer risk: the breast cancer health disparities study.端粒长度、端粒相关基因与乳腺癌风险:乳腺癌健康差异研究。
Genes Chromosomes Cancer. 2013 Jul;52(7):595-609. doi: 10.1002/gcc.22056. Epub 2013 Apr 30.
3
Leukocyte Telomere Length Shortening, hTERT Genetic Polymorphisms and Risk of Childhood Acute Lymphoblastic Leukemia.白细胞端粒长度缩短、hTERT基因多态性与儿童急性淋巴细胞白血病风险
Asian Pac J Cancer Prev. 2018 Jun 25;19(6):1515-1521. doi: 10.22034/APJCP.2018.19.6.1515.
4
Genetic polymorphisms in telomere pathway genes, telomere length, and breast cancer survival.端粒通路基因的遗传多态性、端粒长度与乳腺癌生存。
Breast Cancer Res Treat. 2012 Jul;134(1):393-400. doi: 10.1007/s10549-012-2058-9. Epub 2012 Apr 12.
5
Association of the Telomerase Reverse Transcriptase rs10069690 Polymorphism with the Risk, Age at Onset and Prognosis of Triple Negative Breast Cancer.端粒酶逆转录酶 rs10069690 多态性与三阴性乳腺癌风险、发病年龄和预后的关系。
Int J Mol Sci. 2023 Jan 17;24(3):1825. doi: 10.3390/ijms24031825.
6
Multiple independent variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancer.多个位于 TERT 基因座的独立变体与端粒长度和乳腺癌及卵巢癌的风险相关。
Nat Genet. 2013 Apr;45(4):371-84, 384e1-2. doi: 10.1038/ng.2566.
7
Discriminating association of a common telomerase reverse transcriptase promoter polymorphism with telomere parameters in non-small cell lung cancer with or without epidermal growth factor receptor mutation.区分端粒酶逆转录酶启动子常见多态性与非小细胞肺癌端粒参数的关联,无论表皮生长因子受体突变与否。
Eur J Cancer. 2019 Oct;120:10-19. doi: 10.1016/j.ejca.2019.06.024. Epub 2019 Aug 22.
8
No association between TERT-CLPTM1L single nucleotide polymorphism rs401681 and mean telomere length or cancer risk.TERT-CLPTM1L 单核苷酸多态性 rs401681 与端粒平均长度或癌症风险之间没有关联。
Cancer Epidemiol Biomarkers Prev. 2010 Jul;19(7):1862-5. doi: 10.1158/1055-9965.EPI-10-0281. Epub 2010 Jun 22.
9
MYC amplification and TERT expression in breast tumor progression.MYC扩增与TERT表达在乳腺肿瘤进展中的作用
Cancer Genet Cytogenet. 2007 Jul 15;176(2):93-9. doi: 10.1016/j.cancergencyto.2007.04.002.
10
Possible association of the TERT promoter polymorphisms rs2735940, rs7712562 and rs2853669 with diabetes mellitus in obese elderly Polish population: results from the national PolSenior study.TERT启动子多态性rs2735940、rs7712562和rs2853669与波兰肥胖老年人群糖尿病之间的可能关联:全国性PolSenior研究结果
J Appl Genet. 2018 Aug;59(3):291-299. doi: 10.1007/s13353-018-0450-9. Epub 2018 Jun 25.

引用本文的文献

1
TERT-TP53 mutations: a novel biomarker pair for hepatocellular carcinoma recurrence and prognosis.端粒酶逆转录酶-TP53突变:一种用于肝细胞癌复发和预后的新型生物标志物组合
Sci Rep. 2025 Jan 29;15(1):3620. doi: 10.1038/s41598-025-87545-z.
2
Association of telomerase reverse transcriptase gene rs10069690 variant with cancer risk: an updated meta-analysis.端粒酶逆转录酶基因 rs10069690 变体与癌症风险的关联:一项更新的荟萃分析。
BMC Cancer. 2024 Aug 27;24(1):1059. doi: 10.1186/s12885-024-12833-2.
3
Comparison of anti-cancer effects of platinum ribavirin and ribavirin via telomerase and Bcl-2 gene expression.

本文引用的文献

1
p53 signaling in cancer progression and therapy.p53信号通路在癌症进展与治疗中的作用
Cancer Cell Int. 2021 Dec 24;21(1):703. doi: 10.1186/s12935-021-02396-8.
2
Large-scale cross-cancer fine-mapping of the 5p15.33 region reveals multiple independent signals.5p15.33区域的大规模跨癌症精细定位揭示了多个独立信号。
HGG Adv. 2021 Jul 8;2(3):100041. doi: 10.1016/j.xhgg.2021.100041. Epub 2021 Jun 12.
3
From to Polygenic Risk Scores: Mutation-Associated Risks in Breast Cancer-Related Genes.从多基因风险评分到:乳腺癌相关基因中的突变相关风险。
通过端粒酶和Bcl-2基因表达比较铂-利巴韦林和利巴韦林的抗癌作用
Naunyn Schmiedebergs Arch Pharmacol. 2024 Jun;397(6):3907-3915. doi: 10.1007/s00210-023-02841-7. Epub 2023 Nov 17.
4
No evident causal association between Helicobacter pylori infection and colorectal cancer: a bidirectional mendelian randomization study.幽门螺杆菌感染与结直肠癌之间无明显因果关联:一项双向孟德尔随机化研究。
Sci Rep. 2023 Oct 29;13(1):18544. doi: 10.1038/s41598-023-45545-x.
5
Study of anticancer effects of platinum levetiracetam and levetiracetam via cancer biomarkers genes expression on HepG2 cell line.铂类左乙拉西坦与左乙拉西坦通过癌症生物标志物基因表达对 HepG2 细胞系的抗癌作用研究。
Mol Biol Rep. 2023 Nov;50(11):9431-9439. doi: 10.1007/s11033-023-08890-8. Epub 2023 Oct 13.
6
Telomere length and hTERT genetic variants as potential prognostic markers in multiple myeloma.端粒长度和 hTERT 基因变异作为多发性骨髓瘤潜在的预后标志物。
Sci Rep. 2023 Sep 22;13(1):15792. doi: 10.1038/s41598-023-43141-7.
7
The Relevance of Telomerase and Telomere-Associated Proteins in B-Acute Lymphoblastic Leukemia.端粒酶和端粒相关蛋白在 B 急性淋巴细胞白血病中的相关性。
Genes (Basel). 2023 Mar 10;14(3):691. doi: 10.3390/genes14030691.
8
Association of the Telomerase Reverse Transcriptase rs10069690 Polymorphism with the Risk, Age at Onset and Prognosis of Triple Negative Breast Cancer.端粒酶逆转录酶 rs10069690 多态性与三阴性乳腺癌风险、发病年龄和预后的关系。
Int J Mol Sci. 2023 Jan 17;24(3):1825. doi: 10.3390/ijms24031825.
9
Parental Genetics Communicate with Intrauterine Environment to Reprogram Newborn Telomeres and Immunity.父母的遗传学与宫内环境相互作用,重新编程新生儿的端粒和免疫。
Cells. 2022 Nov 25;11(23):3777. doi: 10.3390/cells11233777.
10
TAaCGH Suite for Detecting Cancer-Specific Copy Number Changes Using Topological Signatures.用于使用拓扑特征检测癌症特异性拷贝数变化的TAaCGH套件
Entropy (Basel). 2022 Jun 29;24(7):896. doi: 10.3390/e24070896.
Breast Care (Basel). 2021 Jun;16(3):202-213. doi: 10.1159/000515319. Epub 2021 Mar 31.
4
TERT promoter hotspot mutations and gene amplification in metaplastic breast cancer.化生性乳腺癌中的端粒酶逆转录酶(TERT)启动子热点突变与基因扩增
NPJ Breast Cancer. 2021 Apr 16;7(1):43. doi: 10.1038/s41523-021-00250-8.
5
What do we need to know and understand about p53 to improve its clinical value?我们需要了解和理解 p53 什么才能提高其临床价值?
J Pathol. 2021 Jul;254(4):443-453. doi: 10.1002/path.5677. Epub 2021 May 6.
6
Human TERT promoter polymorphism rs2853669 is associated with cancers: an updated meta-analysis.人类端粒酶逆转录酶启动子多态性 rs2853669 与癌症相关:一项更新的荟萃分析。
Hum Cell. 2021 Jul;34(4):1066-1081. doi: 10.1007/s13577-021-00520-4. Epub 2021 Mar 20.
7
Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries.《全球癌症统计数据 2020:全球 185 个国家和地区 36 种癌症的发病率和死亡率估计》。
CA Cancer J Clin. 2021 May;71(3):209-249. doi: 10.3322/caac.21660. Epub 2021 Feb 4.
8
Telomere length in peripheral blood lymphocytes related to genetic variation in telomerase, prognosis and clinicopathological features in breast cancer patients.外周血淋巴细胞端粒长度与端粒酶的遗传变异、乳腺癌患者的预后和临床病理特征相关。
Mutagenesis. 2020 Dec 31;35(6):491-497. doi: 10.1093/mutage/geaa030.
9
Racial and Ethnic Differences in Multigene Hereditary Cancer Panel Test Results for Women With Breast Cancer.乳腺癌女性多基因遗传性癌症检测结果的种族和民族差异。
J Natl Cancer Inst. 2021 Oct 1;113(10):1429-1433. doi: 10.1093/jnci/djaa167.
10
Heterogeneity of telomerase reverse transcriptase mutation and expression, telomerase activity and telomere length across human cancer cell lines cultured in vitro.人癌细胞系体外培养中端粒酶逆转录酶突变和表达、端粒酶活性和端粒长度的异质性。
Exp Cell Res. 2020 Nov 1;396(1):112298. doi: 10.1016/j.yexcr.2020.112298. Epub 2020 Sep 21.